Entera Bio (ENTX) Other Non-Current Assets (2024 - 2026)
Entera Bio's (ENTX) quarterly Other Non-Current Assets came in at $7.8 million in Q1 2026, down 2.62% YoY from $8.0 million in Q1 2025, and little changed on a QoQ basis from $7.8 million in Q4 2025.
Entera Bio (ENTX) Other Non-Current Assets (2024 - 2026) Analysis & Trends
Entera Bio (ENTX) has 3 years of Other Non-Current Assets data on file, last reported at $7.8 million in Q1 2026.
- Quarterly Other Non-Current Assets fell 2.62% year-over-year to $7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (down 2.62% YoY) and the FY2025 annual result came in at $7.8 million, up 9618.75% from the prior year.
- Other Non-Current Assets steadied at $7.8 million in Q1 2026, from $7.8 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $8.0 million in Q3 2025 to a low of $80000.0 in Q4 2024.
- A 3-year average of $6.6 million and a median of $7.9 million in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2025 — Other Non-Current Assets surged 9618.75% — and 2026, when it retreated 2.62%.
- Tracing ENTX's Other Non-Current Assets over 3 years: stood at $80000.0 in 2024, then surged by 9618.75% to $7.8 million in 2025, then rose by 0.19% to $7.8 million in 2026.
- The last three Other Non-Current Assets figures came in at $7.8 million (Q1 2026), $7.8 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Entera Bio | 161.44 Mn | 150.13 Mn | - | 7.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.12 Mn |
| Mar 31, 2026 | 7.79 Mn |
| Dec 31, 2025 | 7.78 Mn |
| Sep 30, 2025 | 8.03 Mn |
| Jun 30, 2025 | 8.02 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 80,000.00 |